Revolutionary Science Meets Transformative Cancer Therapy
Seattle Genetics is dedicated to improving patient outcomes with transformative therapies targeting cancer
From Promise to Therapy
Seattle Genetics is conducting clinical trials in these and other therapeutic areas:
- Hodgkin lymphoma
- Non-Hodgkin lymphoma
- Urothelial cancer
- Breast cancer
Join The Seattle Genetics Team
We are a group of passionate innovators dedicated to positively impacting the lives of those living with cancer, and we're always looking to add to our team.
Recent News
Seattle Genetics At A Glance
| Year founded | 1998 |
|
| Global Headquarters | Bothell, WA |
|
| Nasdaq | SGEN |
|
| Number of Employees | 1,225+ |
|
| ADC Collaborations | Multiple ADC technology licensing agreements |
|
-
#ICYMI: Read about our #FDA approval, which we received 11 days after sBLA submission under the Real-Time Oncology… twitter.com/i/web/status/1… · 4 days ago
-
Peripheral T-cell #lymphoma (PTCL) is an aggressive form of non-Hodgkin lymphoma. PTCL accounts for approximately… twitter.com/i/web/status/1… · 4 days ago
-
Thank you to the patients and researchers who participated in our ECHELON-2 clinical trial that led to today’s #FDA… twitter.com/i/web/status/1… · 4 days ago
